Xenon Pharmaceuticals Inc (XENE) — Strategic Asset Allocation Index
Xenon Pharmaceuticals Inc (XENE) has a Strategic Asset Allocation Index of 16.6% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $92.99 Million) total $92.99 Million, measured against net assets of $559.51 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Xenon Pharmaceuticals Inc Strategic Asset Allocation Index (2012–2024)
This chart shows how Xenon Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 16.6%, representing strategic assets of $92.99 Million against net assets of $559.51 Million USD. Explore XENE cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Xenon Pharmaceuticals Inc (2012–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Xenon Pharmaceuticals Inc from 2012 to 2024, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Xenon Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 16.9% | $127.50 Million | $- | $127.50 Million | $754.90 Million | ▼ -14.7 pp |
| 2023 | 31.6% | $292.79 Million | $- | $292.79 Million | $927.92 Million | ▲ +12.8 pp |
| 2022 | 18.7% | $135.18 Million | $6.50 Million | $128.68 Million | $721.50 Million | ▲ +17.9 pp |
| 2021 | 0.8% | $4.47 Million | $4.47 Million | $0.00 | $550.03 Million | ▼ -1.3 pp |
| 2020 | 2.1% | $3.55 Million | $3.55 Million | $- | $171.35 Million | ▲ +0.3 pp |
| 2019 | 1.8% | $1.66 Million | $1.66 Million | $- | $91.98 Million | ▲ +0.8 pp |
| 2018 | 1.0% | $991.00K | $991.00K | $- | $103.30 Million | ▼ -2.0 pp |
| 2017 | 3.0% | $1.07 Million | $1.07 Million | $- | $35.93 Million | ▲ +0.8 pp |
| 2016 | 2.2% | $1.40 Million | $1.40 Million | $- | $63.90 Million | ▼ -1.1 pp |
| 2015 | 3.3% | $1.99 Million | $1.99 Million | $- | $61.03 Million | ▼ -0.1 pp |
| 2014 | 3.4% | $2.48 Million | $2.48 Million | $- | $72.78 Million | ▼ -4.4 pp |
| 2013 | 7.8% | $1.88 Million | $1.88 Million | $- | $24.12 Million | ▼ -12.8 pp |
| 2012 | 20.6% | $2.60 Million | $2.60 Million | $- | $12.62 Million | — |